Raymond James analyst Pavel Molchanov maintains Enviva Partners (NYSE:EVA) with a Outperform and raises the price target from $57 to $75.
Raymond James Maintains Outperform on Enviva Partners, Raises Price Target to $75
Raymond James analyst Pavel Molchanov maintains Enviva Partners (NYSE:EVA) with a Outperform and raises the price target from $57 to $75.
Related Posts
Deutsche Bank Maintains Hold on The Western Union, Lowers Price Target to $13
Deutsche Bank analyst Bryan Keane maintains The Western Union (NYSE:WU) with a Hold and lowers the price target from $18 to $13.
HC Wainwright & Co. Maintains Buy on Verrica Pharmaceuticals, Lowers Price Target to $20
HC Wainwright & Co. analyst Oren Livnat maintains Verrica Pharmaceuticals (NASDAQ:VRCA) with a Buy and lowers the price target from $24 to $20.
Despite Underrepresentation, Black Leaders Are Impacting Every Part Of Cannabis
The history of cannabis in the United States is marked by the exclusion and persecution of people of color, particularly Black Americans. Cannabis prohibition, along with institutional racism, have led to bar many Black people from entry into this multi-billion-dollar industry.